- Home
- GDEV vs LUCD Comparison
GDEV vs LUCD Comparison
Compare GDEV & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDEV | LUCD |
|---|---|---|
| Founded | 2009 | 2018 |
| Country | Cyprus | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.3M | 192.9M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GDEV | LUCD |
|---|---|---|
| Price | $9.42 | $0.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 937.0 | ★ 8.1M |
| Earning Date | 11-23-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,346,000.00 |
| Revenue This Year | $7.58 | $33.93 |
| Revenue Next Year | $6.90 | $165.18 |
| P/E Ratio | $5.19 | ★ N/A |
| Revenue Growth | N/A | ★ 79.00 |
| 52 Week Low | $9.00 | $0.30 |
| 52 Week High | $25.30 | $1.63 |
Technical Indicators
Market Signals| Indicator | GDEV | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 37.86 | 35.55 |
| Support Level | N/A | $0.30 |
| Resistance Level | $12.08 | $1.09 |
| Average True Range (ATR) | 0.34 | 0.07 |
| MACD | -0.16 | 0.01 |
| Stochastic Oscillator | 15.01 | 32.35 |
Price Performance
Historical ComparisonAbout GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.